SF 2470(200 KB) -- Signed into law by Gov. Mark Dayton on May 29, 2014 Approved: By Senate 46-16, by House 89-40 Effective: May 30, 2014
Approved Conditions: cancer
(if the underlying condition or treatment produces severe or chronic
pain, nausea or severe vomiting, or cachexia or severe wasting),
glaucoma, HIV/AIDS, Tourette's syndorme, ALS, seizures/epilepsy, severe
and persistent muscle spasms/MS, Crohn's disease, terminal illness with a
life expectancy of under one year.
The commissioner will consider adding intractable pain and other
conditions, and must report findings no later than July 1, 2016.
Commissioner of Health will register two in-state manufacturers for the
production of all medical cannabis within the state. Manufacturers are
required to ensure that the medical cannabis distributed contains a
maximum of a 30-day supply of the dosage determined for that patient.
"Medical cannabis" is defined as any species of the genus cannabis
plant delivered in the form of (1) liquid, including, but not limited
to, oil; (2) pill; (3) vaporized delivery method that does not require
the use of dried leaves or plant form. Smoking is not a method approved by the bill.
Information provided by the state on sources for medical marijuana:
Manufacturers shall operate four distribution facilities in the
state and must agree to begin supplying medical cannabis to patients by
July 1, 2015 from at least one facility.
Patient Registry Fee:
$200 / $50 for patients on Social Security disability, Supplemental Security Insurance, or enrolled in MinnesotaCare